))
Limitations of the Current Therapeutics Used to Manage CIAS
Manage episode 415617686 series 3381434
Innehåll tillhandahållet av ReachMD. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av ReachMD eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
CME credits: 1.00
Valid until: 30-04-2025
Claim your CME credit at https://reachmd.com/programs/cme/program-name/20297/
This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophysiology, diagnosis, and emerging therapies to treat cognitive impairment associated with schizophrenia.
…
continue reading
Valid until: 30-04-2025
Claim your CME credit at https://reachmd.com/programs/cme/program-name/20297/
This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophysiology, diagnosis, and emerging therapies to treat cognitive impairment associated with schizophrenia.
691 episoder
Dela
